OSE Immunotherapeutics Announces Granting of First European Patent Protecting Anti-IL-7 …

17th February 2021

… strengthened intellectual property rights for its anti-interleukin-7 receptor (IL-7R) antagonist OSE-127/S95011 through the granting of a first patent by …